| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 452.217.838 $ | +51.344.826 $ | +16,5 % | 10 | 413.637.956 $ | +139.535.898 $ | +51,6 % | 10 | 192.809.279 $ | +88.570.265 $ | +61,3 % | 5 | ||||
| UNITED THERAPEUTICS Corp | UTHR | → 0 | Neutral | 62.100.423 $ | +31.121.068 $ | +100,5 % | 1 | 35.766.159 $ | +35.766.159 $ | 1 | |||||
| Abivax S.A. | ABVX | → 0 | Schwach | 51.874.513 $ | +463.337 $ | +0,9 % | 1 | 51.411.176 $ | +26.635.658 $ | +107,5 % | 1 | ||||
| BridgeBio Pharma, Inc. | BBIO | → 0 | Sehr schwach | 51.664.019 $ | +6.116.289 $ | +13,4 % | 1 | 45.547.730 $ | +14.917.206 $ | +48,7 % | 1 | ||||
| Revolution Medicines, Inc. | RVMD | → 0 | Schwach | 45.549.566 $ | -5.297.799 $ | -10,4 % | 1 | 50.847.365 $ | +20.816.930 $ | +69,3 % | 1 | ||||
| INSMED Inc | INSM | → 0 | Neutral | 40.630.632 $ | -5.366.922 $ | -11,7 % | 1 | 45.997.554 $ | -52.956 $ | -0,1 % | 1 | 46.050.510 $ | +8.544.800 $ | +22,8 % | 1 |
| Xenon Pharmaceuticals Inc. | XENE | → 0 | Neutral | 45.754.979 $ | +9.910.498 $ | +27,6 % | 1 | 35.844.481 $ | +3.734.800 $ | +11,6 % | 1 | ||||
| Apogee Therapeutics, Inc. | APGE | → 0 | Schwach | 43.244.021 $ | +7.403.173 $ | +20,7 % | 1 | 35.840.848 $ | +19.837.167 $ | +124,0 % | 1 | ||||
| Mirum Pharmaceuticals, Inc. | MIRM | → 0 | Neutral | 36.994.864 $ | -1.043.876 $ | -2,7 % | 1 | 38.038.740 $ | -3.789.673 $ | -9,1 % | 1 | 41.828.413 $ | +14.981.902 $ | +55,8 % | 1 |
| Nuvalent, Inc. | NUVL | → 0 | 37.941.743 $ | +854.512 $ | +2,3 % | 1 | 37.087.231 $ | +2.948.905 $ | +8,6 % | 1 | 34.138.326 $ | +9.661.439 $ | +39,5 % | 1 | |
| Axsome Therapeutics, Inc. | AXSM | → 0 | Schwach | 37.792.051 $ | +19.257.081 $ | +103,9 % | 1 | ||||||||
| Cogent Biosciences, Inc. | COGT | → 0 | Neutral | 36.463.078 $ | +7.184.546 $ | +24,5 % | 1 | ||||||||
| Terns Pharmaceuticals, Inc. | TERN | → 0 | 35.230.780 $ | +35.230.780 $ | 1 | ||||||||||
| Merus N.V. | → 0 | 35.025.871 $ | +19.615.965 $ | +127,3 % | 1 | ||||||||||
| 452.217.838 $ | +51.344.826 $ | +16,5 % | 10 | 413.637.956 $ | +139.535.898 $ | +51,6 % | 10 | 192.809.279 $ | +88.570.265 $ | +61,3 % | 5 | ||||